Caitlin Roberts

Stock Analyst at Canaccord Genuity

(4.47)
# 1,127
Out of 5,090 analysts
156
Total ratings
62.5%
Success rate
16.8%
Average return

Stocks Rated by Caitlin Roberts

Stryker
Oct 30, 2026
Downgraded: Hold
Price Target: $385 → $300
Current: $291.86
Upside: +2.79%
Axogen
Oct 29, 2026
Reiterated: Buy
Price Target: $55 → $60
Current: $49.37
Upside: +21.53%
Establishment Labs Holdings
Oct 29, 2026
Reiterated: Buy
Price Target: $105
Current: $62.46
Upside: +68.11%
OrthoPediatrics
Oct 28, 2026
Reiterated: Buy
Price Target: $28 → $30
Current: $30.87
Upside: -2.82%
InMode
Oct 14, 2026
Reiterated: Hold
Price Target: $15
Current: $13.22
Upside: +13.46%
SI-BONE
Oct 14, 2026
Reiterated: Buy
Price Target: $27
Current: $21.23
Upside: +27.18%
Smith & Nephew
Sep 23, 2026
Reiterated: Hold
Price Target: $30
Current: $29.70
Upside: +1.01%
Enovis
Sep 1, 2026
Reiterated: Buy
Price Target: $45
Current: $19.91
Upside: +126.02%
Orthofix Medical
Aug 31, 2026
Reiterated: Buy
Price Target: $13
Current: $9.07
Upside: +43.33%
TELA Bio
Aug 31, 2026
Reiterated: Buy
Price Target: $2
Current: $0.8101
Upside: +146.88%
Reiterated: Buy
Price Target: $115
Current: $78.05
Upside: +47.34%
Reiterated: Buy
Price Target: $15 → $19
Current: $13.33
Upside: +42.59%
Reiterated: Buy
Price Target: $6
Current: $2.99
Upside: +100.67%
Reiterated: Buy
Price Target: $83 → $100
Current: $94.52
Upside: +5.80%
Reiterated: Buy
Price Target: $58
Current: $40.26
Upside: +44.06%
Reiterated: Buy
Price Target: $25 → $23
Current: $7.04
Upside: +226.70%